Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01143402
First received: June 11, 2010
Last updated: September 16, 2014
Last verified: August 2014